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Skp2-Mediated Degradation of p27
Regulates Progression into Mitosis
G0 phase but rapidly decreases on the reentry of cells
into G1-S. Moreover, we and others have demonstrated
that p27/ mice are larger than normal mice and exhibit
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both multiple organ hyperplasia and a predisposition toMasatoshi Kitagawa,2,3 Shun-ichiro Iemura,4
the development of tumors (Fero et al., 1996; KiyokawaTohru Natsume,4 and Keiichi I. Nakayama2,3,*
et al., 1996; Nakayama et al., 1996).1Division of Developmental Genetics
The intracellular concentration of p27 is thought toCenter for Translational and Advanced Animal
be regulated predominantly by the ubiquitin-mediatedResearch on Human Diseases
proteolytic pathway (Pagano et al., 1995; Shirane et al.,Tohoku University School of Medicine
1999). Degradation of p27 is promoted by its phosphory-Sendai, Miyagi 980-8575
lation on Thr187 by the cyclin E-Cdk2 complex (Sheaff etJapan
al., 1997; Vlach et al., 1997; Montagnoli et al., 1999).2 CREST
Skp2, an F box protein that functions as the receptorJapan Science and Technology Corporation (JST)
component of an SCF ubiquitin ligase complex, bindsKawaguchi, Saitama 332-0012
to p27 only when Thr187 of this CKI is phosphorylated;Japan
such binding then results in the ubiquitylation and deg-3 Department of Molecular and Cellular Biology
radation of p27 (Carrano et al., 1999; Sutterluty et al.,Medical Institute of Bioregulation
1999; Tsvetkov et al., 1999). Skp2 also targets free cyclinKyushu University
E (not that complexed with Cdk2) for ubiquitylation (Na-Fukuoka, Fukuoka 812-8582
kayama et al., 2000). These biochemical observationsJapan
are supported by genetic evidence showing that both4 National Institute of Advanced Industrial Science
p27 and free cyclin E accumulate to high levels in theand Technology (AIST)
cells of mice that lack Skp2 (Nakayama et al., 2000,Biological Information Research Center
2001). The most obvious cellular phenotype of Skp2/Tokyo 135-0064
mice is the presence of markedly enlarged, polyploidJapan
nuclei and multiple centrosomes, suggestive of an im-
pairment in the mechanism that prevents endoreplica-
tion, in which the genomic DNA content of a cell isSummary
increased without cell division. In addition to p27 and
free cyclin E, several other substrates have been pro-Although Skp2 has been thought to mediate the degra-
posed for Skp2. However, some of these potential sub-dation of p27 at the G1-S transition, Skp2/ cells ex-
strates were found not to accumulate in cells fromhibit accumulation of p27 in S-G2 phase with overrepli-
Skp2/ mice, suggesting either that they are not bonacation. We demonstrate that Skp2/p27/ mice do
fide Skp2 substrates or that functional redundancynot exhibit the overreplication phenotype, suggesting
allows for their ubiquitylation in the absence of Skp2.that p27 accumulation is required for its development.
Skp2 is almost undetectable or expressed at a lowHepatocytes of Skp2/ mice entered the endodupli-
level in G0 and early to mid-G1 phase. It begins to accu-cation cycle after mitogenic stimulation, whereas this
mulate during late G1 phase, and its abundance is maxi-phenotype was not apparent in Skp2/p27/ mice.
mal during S and G2 phases (Hara et al., 2001). The onsetCdc2-associated kinase activity was lower in Skp2/
of Skp2 expression is unequivocally later than that ofcells than in wild-type cells, and a reduction in Cdc2
the degradation of p27 apparent at G0-G1. Moreover,activity was sufficient to induce overreplication. The
p27 is exported from the nucleus to the cytoplasm at
lack of p27 degradation in G2 phase in Skp2/ cells G0-G1 (Rodier et al., 2001; Ishida et al., 2002; Connor etmay thus result in suppression of Cdc2 activity and al., 2003), whereas Skp2 is restricted to the nucleus
consequent inhibition of entry into M phase. These (Miura et al., 1999). The discrepancies between the tem-
data suggest that p27 proteolysis is necessary for the poral and spatial patterns of p27 expression and those
activation of not only Cdk2 but also Cdc2, and that of Skp2 expression suggest the existence of an Skp2-
Skp2 contributes to regulation of G2-M progression by independent pathway for the degradation of p27 at the
mediating the degradation of p27. G0-G1 transition. Indeed, the downregulation of p27 at
G0-G1 occurs normally in Skp2/ cells, but that in S and
Introduction G2 phases is impaired (Hara et al., 2001). These findings
suggest that the major role of Skp2 might be to reduce
The highly ordered progression of the cell cycle is the concentration of p27 during S and G2 phases rather
achieved by a series of elaborate mechanisms that con- than at late G1 phase.
trol the periodic expression of many regulatory proteins. To determine whether the accumulation of p27 is es-
One such regulatory protein is the Cdk inhibitor (CKI) sential for the polyploidy and centrosome overdup-
p27. In normal cells, the amount of p27 is high during lication in Skp2/ cells, we generated double mutant
mice that lack both Skp2 and p27 genes. We now show
that, although cyclin E accumulates in the cells of*Correspondence: nakayak1@bioreg.kyushu-u.ac.jp
5 These authors contributed equally to this work. Skp2/ p27/ mice, the markedly enlarged, polyploid
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body size of the Skp2/ p27/ double mutant was
slightly larger than that of wild-type controls. We also
examined the size of the thymus, which is one of the
most affected organs in Skp2/ or p27/ mice; it is
hyperplastic in p27/ mice and atrophic in Skp2/ mice
(Figure 1C). As with body size, the thymus of Skp2/
p27/ mice was slightly larger than that of wild-type
animals. In general, the Skp2/ p27/ mice appeared
similar to p27/ mice and exhibited phenotypes oppo-
site to those of Skp2/ mice. The observation that the
Skp2/ p27/ double mutant appears similar but not
identical to the p27/ single mutant constitutes genetic
evidence for the notion that, although p27 is the main
target of Skp2, Skp2 may also mediate the ubiquitylation
of other substrates.
Absence of Overreplication Phenotype
in Skp2/ p27/ Mice
The most obvious cellular phenotype of Skp2/ mice
is the presence of markedly enlarged, polyploid nuclei
and multiple centrosomes (Nakayama et al., 2000). To
determine whether these characteristics are dependent
on p27 accumulation, we examined liver, kidney, and
lung cells of wild-type, Skp2/, p27/, and Skp2/
p27/ mice (Figures 2A–2L). As previously described,
the nuclei of hepatocytes, renal tubule cells, and bron-
chiolar epithelial cells of Skp2/mice were substantially
larger than those of the corresponding cells in wild-type
littermates. Such nuclear enlargement was not apparent
in the cells of p27/ or Skp2/ p27/ mice. Flow cy-
tometry also revealed that the DNA content of hepato-
cytes from Skp2/ mice ranged from 2C to 16C,
whereas that of most hepatocytes from wild-type or
p27/ animals was 2C or 4C (Figures 2M–2O). The per-
centage of polyploid cells in Skp2/ p27/ mice was
Figure 1. Body and Thymus Size in Skp2/ p27/ Mice
greatly reduced compared with that in Skp2/ mice,
(A) Representative male wild-type (WT), p27/, Skp2/, and
although the double mutant did exhibit a small increaseSkp2/ p27/ littermates at 8 weeks of age.
in the number of 8C cells relative to that in wild-type(B) Representative growth curves for male wild-type, p27/,
animals (Figure 2P).Skp2/, and Skp2/ p27/ mice. Similar differences in body
weight were apparent for female mice of the various genotypes With the use of fluorescence microscopy, we also
(data not shown). examined the nuclear size (as revealed by Hoechst
(C) Gross appearance of the thymus of male wild-type, p27/, 33258 staining) and centrosome number (as revealed
Skp2/, and Skp2/ p27/ littermates at 8 weeks of age. Scale by immunostaining with antibodies to pericentrin) of cul-
bar, 5 mm.
tured mouse embryonic fibroblasts (MEFs) derived from
the various mice. As with liver, kidney, and lung cells,
nuclei and multiple centrosomes associated with Skp2 MEFs derived from Skp2/ mice exhibited a markedly
deficiency are not evident in the double mutant mice. enlarged nucleus, whereas the nuclear size of Skp2/
These data suggest that accumulation of p27 is primarily p27/ MEFs was similar to that of wild-type MEFs (Fig-
responsible for this cellular phenotype of Skp2/ mice. ures 2Q–2S). The number of centrosomes, which was
We also demonstrate that the aberrant increase in p27 increased in the Skp2/ MEFs, also appeared normal
expression in Skp2/ cells results in inhibition of the in the Skp2/ p27/ cells (Figures 2T–2W). These ob-
kinase activity of Cdc2 and a consequent block of servations indicate that the cellular phenotype of
entry into M phase. Our results thus indicate that Skp2 Skp2/ mice is dependent on the presence of an intact
plays a crucial role in regulation of G2-M progression by p27 gene.
contributing to the ubiquitylation-mediated proteolysis Mice lacking p27 manifest multiple organ hyperplasia,
of p27. retinal dysplasia, and pituitary tumors (Fero et al., 1996;
Kiyokawa et al., 1996; Nakayama et al., 1996). The most
Results hyperplastic organs in these animals are the thymus,
testis, ovary, adrenal medulla, and intermediate lobe of
Generation of Mice Lacking Both Skp2 and p27 the pituitary gland. Histopathologic examination re-
To generate mice lacking Skp2 and p27, we crossed vealed that the adrenal medulla of Skp2/ p27/ mice
Skp2/ p27/ animals. As we previously described is as hyperplastic as is that of p27/ mice, whereas that
(Nakayama et al., 1996, 2000), the body size of p27/ of Skp2/ mice appeared hypoplastic (Figures 3A–3D).
animals is larger and that of Skp2/ mice is smaller Similarly, the intermediate lobe of the pituitary, a vesti-
gial structure in adult humans, was hyperplastic in boththan that of wild-type controls (Figures 1A and 1B). The
Role of Skp2 in G2-M Progression
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Figure 2. Absence of Nuclear Enlargement
and Polyploidy in Skp2/ p27/ Mice
(A–L) Histological analysis of liver (A–D), renal
tubules (E–H), and bronchioles (I–L) of adult
wild-type (A, E, and I), Skp2/ (B, F, and J),
p27/ (C, G, and K), and Skp2/ p27/ (D,
H, and L) mice. Sections were stained with
Feulgen solution (A–D) or with hematoxylin-
eosin (E–L). Scale bars, 25 m.
(M–P) Flow cytometric analysis of the DNA
content of hepatocytes from wild-type (M),
Skp2/ (N), p27/ (O), and Skp2/ p27/
(P) mice.
(Q–W) Normal nuclear size and centrosome
number of Skp2/ p27/ cells. MEFs de-
rived from wild-type (Q and T), Skp2/ (R and
U), and Skp2/ p27/ (S and V) embryos
were stained either with both antibodies
to -tubulin and Hoechst 33258 (Q–S) or
with antibodies to pericentrin alone (T–V).
-tubulin and pericentrin immune complexes
are represented by red and green staining,
respectively. Centrosomes are indicated by ar-
rowheads. Blue staining represents Hoechst
33258 labeling of nuclear DNA. Scale bars,
10 m. The percentages of MEFs either with
one or two or with more than two centro-
somes were determined by analysis of 400
cells per genotype (W).
p27/ and Skp2/ p27/ mice (Figures 3E–3H). The difference between wild-type and Skp2/ mice (Figure
4C). Mitotic cells in the liver were evaluated by hematox-intermediate lobe of these animals contained a large
ylin-eosin staining (data not shown) and immunostainingnumber of atypical cells; both p27/and Skp2/p27/
with antibodies to phosphorylated histone H3 (Figuresmice were thus diagnosed with benign pituitary ade-
4D–4G), which is a marker for cells in M phase. In wild-noma. Furthermore, histopathologic examination of the
type mice, cells containing phosphorylated histone H3retina of Skp2/ p27/ mice revealed a marked disor-
were apparent and peaked in number 5 days after estriolganization of the cellular layers in the neural retina, simi-
administration (Figure 4H). In contrast, no cells that re-lar to that apparent in p27/ mice (Figures 3I–3L). These
acted with the antibodies to the phosphorylated histoneobservations demonstrate that Skp2/ p27/ double
were detected at any time after estriol treatment inmutant mice preserve the phenotypes of p27/ mice.
Skp2/ mice. This lack of M phase induction in re-They therefore constitute genetic evidence in support
sponse to estriol appeared to be attributable to p27of the notion that Skp2 is an upstream regulator of p27,
accumulation, given that the liver of Skp2/ p27/ micealthough slight differences between p27/ and Skp2/
responded in a manner similar to that of the liver of wild-p27/ mice may reflect other possible functions of
type mice (Figure 4G). These results thus suggested thatSkp2.
Skp2/ cells are able to enter S phase but not M phase,
a characteristic of endoreplication, although a mitotic
Impaired Entry into M Phase in Skp2/ Cells defect could also account for this abnormality. They
We hypothesized that the nuclear enlargement, poly- also indicate that the inability of Skp2/ cells to enter
ploidy, and centrosome overduplication apparent in M phase is due to the abnormal accumulation of p27.
Skp2/ cells result from reentry of the cells into S phase
without passage through M phase. To test this hypothe- Impairment of Mitotic Entry Induced
sis, we orally administered the female hormone estriol, by a Reduction in Cdc2 Activity
which transiently stimulates hepatocyte proliferation In fission yeast, overexpression of the CKI Rum1 inhibits
(Fujii et al., 1985), to adult wild-type, Skp2/, p27/, mitotic cyclin-Cdc2 activity and thereby prevents mito-
and Skp2/ p27/ mice. The giant cells observed in sis (Correa-Bordes and Nurse, 1995). Moreover, a high
the liver of Skp2/ mice were shown to have entered activity of the mitotic cyclin-Cdc2 complex prevents
S phase by their incorporation of 5-bromo-2-deoxyuri- chromosome replication (Stern and Nurse, 1996). These
dine (BrdU) that was injected intraperitoneally (Figures observations led us to test the hypothesis that accumu-
4A and 4B). Monitoring of the time-dependent increase lation of the CKI p27 during G2 phase inhibits mitotic
cyclin-Cdc2 activity in mammalian Skp2/ cells.in the percentage of cells in S phase revealed no marked
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Figure 3. Organ Hyperplasia in Skp2/
p27/ Mice
Histological sections of the adrenal gland
(A–D), pituitary gland (E–H), and retina (I–L)
of wild-type (A, E, and I), Skp2/ (B, F, and
J), p27/ (C, G, and K), and Skp2/ p27/
(D, H, and L) mice are shown. The paraffin-
embedded sections were stained with hema-
toxylin-eosin. Abbreviations: Cx, cortex; Me,
medulla; Ant, anterior lobe; Int, intermediate
lobe; Pos, posterior lobe. Arrowheads in (K)
and (L) indicate the outer granular layer invad-
ing the layer of rods and cones beyond the
outer limiting membrane of the retina. Scale
bars: 400 m (A–D), 100 m (E–H), and 25
m (I–L).
We compared the abundance (Figure 5A) and kinase the Skp2/ cells, suggesting that the accumulated p27
antagonized the kinase activity. Consistent with this no-activities (Figure 5B) of various cell cycle regulators in
MEFs derived from wild-type, Skp2/, p27/, and tion, the activity of cyclin E-associated kinase activity
was increased in Skp2/ p27/ MEFs.Skp2/ p27/ mice. There were no marked differences
in the amounts of cyclin A, cyclin B, Cdk2, or Cdc2 or We found that p27 associated with Cdc2, although to
only a small extent, in wild-type MEFs (Figure 5C). Thein the kinase activity associated with Cdk2 among the
four types of cells. In contrast to lymphocytes, which amount of Cdc2 bound to endogenous p27 was mark-
edly increased in Skp2/ cells, however. The phosphor-express p27 but not p57 (Nagahama et al., 2001), and
in which the loss of p27 results in a marked increase in ylation status of tyrosine-15 and threonine-161 of Cdc2
was similar among the four genotypes of MEFs (Supple-the kinase activity of Cdk2 (Nakayama et al., 1996),
p27/ MEFs did not exhibit an increase in such activity, mental Figure S1 at http://www.developmentalcell.com/
cgi/content/full/6/5/661/DC1), excluding the possibilityprobably because of the presence of p57. Cyclin A-,
cyclin B-, or Cdc2-associated kinase activity was sub- that the loss of Skp2 or accumulation of p27 affects
other molecules that regulate Cdc2 activity directly. Thestantially reduced in Skp2/ cells compared with that
in MEFs of the other three genotypes, however. The amount of Cdk2 associated with p27 was also increased
in Skp2/ cells (Figure 5C). In contrast, the amount ofobservation that Skp2/ p27/ MEFs differed from
Skp2/ cells in this regard suggests that accumulation Cdk4 associated with p27 was not affected by the loss
of Skp2, which might be explained if the amount of Cdk4of p27 is responsible for the low kinase activity of cyclin
A-Cdc2 or cyclin B-Cdc2 in Skp2/ cells. Cyclin is limited and most of it is bound to p27 even in wild-
type cells; the excess p27 that overflows from the Cdk4-E-associated kinase activity was not increased, even
though the abundance of cyclin E was increased, in bound pool would then be available to bind to Cdk2 or
Role of Skp2 in G2-M Progression
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Figure 4. Defective Entry into M Phase of He-
patocytes Exposed to Mitogenic Stimulation
in Adult Skp2/ Mice
Adult mice were subjected to a single oral
administration of estriol and daily intraperito-
neal injection of BrdU. They were killed at
various times after estriol administration and
sections of the liver were processed for im-
munostaining.
(A and B) Liver sections prepared from wild-
type (A) and Skp2/ (B) mice 5 days after
administration of estriol were subjected to
immunostaining with antibodies to BrdU
(brown).
(C) The percentage of liver cells that stained
with the antibodies to BrdU was determined
for wild-type and Skp2/ mice at the indi-
cated times after administration of estriol.
(D–G) Liver sections prepared from wild-type
(D), Skp2/ (E), p27/ (F), and Skp2/
p27/ (G) mice 5 days after estriol adminis-
tration were stained with antibodies to phos-
phorylated histone H3 (red) and Hoechst
33258 (blue).
(H) The percentage of liver cells that stained
with the antibodies to phosphorylated his-
tone H3 (mitotic index) was determined for
wild-type and Skp2/ mice at the indicated
times after administration of estriol.
Data in (C) and (H) are from representative
animals. Scale bars: 50 m (A and B) and 25
m (D–G).
Cdc2 in Skp2/ MEFs. Immunodepletion of p27 also increased by treatment with butyrolactone I (Figure 6D).
Given that this compound may affect other types ofreduced the amounts of Cdc2 and Cdk2 in Skp2/ cell
lysates (data now shown), confirming that a substantial Cdk, we also examined FT210 cells, which express a
temperature-sensitive mutant of Cdc2 (Th’ng et al.,proportion of Cdc2 and Cdk2 is bound to endogenous
p27. We also found that FLAG epitope-tagged exoge- 1990). FM210 cells cultured at the restrictive tempera-
ture (39C) exhibited huge nuclei and multiple centro-nous p27 interacted with endogenous cyclin A, cyclin
B, Cdk2, and Cdc2 as well as inhibited the associated somes (Figure 6H); neither FM210 cells cultured at the
permissive temperature (32C) (Figure 6G) nor the paren-kinase activities in COS-7 cells (Figure 5D). Mass spec-
trometric analysis of immunoprecipitates prepared from tal cell line, FM3A, cultured at either temperature (Fig-
ures 6E and 6F) exhibited this phenotype. Flow cytomet-HEK293T cells expressing FLAG-tagged p27 with anti-
bodies to FLAG showed that p27 is complexed with ric analysis revealed that FT210 cells cultured at the
restrictive temperature, but not those cultured at thecyclin A2, cyclin B1, cyclin B2, cyclin E1, cyclin E2, Cdc2,
Cdk2, Cdk4, and Cdk5 (data not shown). permissive temperature, appeared to be arrested at
the G2-M boundary (Figure 6I) with an increase in cellWe next examined whether the observed decrease in
the kinase activity of Cdc2 is sufficient to explain the size (Figure 6J). These data thus indicate that a reduction
in the kinase activity of Cdc2 results in G2-M arrest asso-overreplication phenotype of Skp2/ cells. We first
treated wild-type MEFs with a potent Cdc2 inhibitor, ciated with nuclear enlargement and centrosome over-
duplication in mammalian cells. In Skp2/ mice, thebutyrolactone I (Kitagawa et al., 1993). Exposure of the
wild-type MEFs to butyrolactone I resulted in nuclear accumulation of p27 due to the lack of its ubiquitylation-
mediated proteolysis likely results in such a decreaseenlargement and centrosome multiplication (Figures 6A
and 6B), characteristics similar to those of Skp2/ in Cdc2 activity.
MEFs. Flow cytometric analysis revealed that the DNA
content of the butyrolactone I-treated cells increased in Accumulation of Cyclin E in Skp2/ p27/ Mice
Given that p27 is an inhibitor of the kinase activity ofmultiples of 2C (Figure 6C), a characteristic of endorepli-
cation, rather than in a continuous manner, as would be cyclin E-Cdk2 and that the phosphorylation of cyclin E
that triggers its degradation is thought to be mediated,consistent with DNA rereplication. Cell size was also
Developmental Cell
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Figure 5. Reduced Cdc2-, Cyclin A-, or
Cyclin B-Associated Kinase Activity in
Skp2/ Cells and Interaction of p27 with
Cdc2, Cdk2, Cyclin A, and Cyclin B
(A and B) Lysates of MEFs from wild-type,
Skp2/, p27/, and Skp2/ p27/ mice
were subjected either to immunoblot analysis
with antibodies to the indicated proteins (A)
or to in vitro assays of Cdc2-, Cdk2-, cyclin
A-, cyclin B-, or cyclin E-associated kinase
activity (B).
(C) Lysates of MEFs from wild-type and
Skp2/ mice were subjected to immunopre-
cipitation (IP) with antibodies to p27, and the
resulting precipitates were subjected to im-
munoblot (IB) analysis with antibodies to the
indicated proteins (left panels). A portion
(10%) of the input lysates was also subjected
directly to immunoblot analysis with the same
antibodies (right panels).
(D) COS-7 cells were transfected with an ex-
pression vector for FLAG-tagged p27 (or with
the empty vector) and with a vector for CD19,
and CD19-expressing cells were then iso-
lated with the use of magnetic beads conju-
gated with antibodies to CD19. Lysates of the
CD19-positive cells were subjected to immu-
noprecipitation with antibodies to FLAG, and
the resulting precipitates were subjected to
immunoblot analysis with antibodies to the
indicated proteins (left panels). Portions
(10%) of the input lysates were also subjected
directly to immunoblot analysis with the same
antibodies (upper right panels) and to in vitro
assays of kinase activity (KA) associated with
the indicated proteins (lower right panels).
IgH, immunoglobulin heavy chain.
at least in part, by associated Cdk2, it was possible that amount of p21 bound to cyclin E was also observed in
Skp2/ p27/ MEFs. Association of p57 with cyclin Ethe accumulation of cyclin E in the cells of Skp2/ mice
was an indirect consequence of p27 accumulation. To was not detected in MEFs of any of the four genotypes
(data not shown). We therefore are not able to excludeinvestigate this possibility, we examined the amount of
cyclin E in MEFs, thymus, testis, and liver of Skp2/ completely the possibility that accumulation of p21 or of
other proteins results in inhibition of cyclin E-associatedp27/ mice. The abundance of cyclin E in these cells
and tissues of the double mutant, however, was mark- kinase activity and thereby stabilizes cyclin E by
blocking its phosphorylation. However, such a possibil-edly greater than that in their wild-type counterparts
and similar to that for Skp2/ mice (Figure 7A), sug- ity seems unlikely because cyclin E-associated kinase
activity was not reduced in Skp2/ MEFs (Figure 5B).gesting that the accumulation of cyclin E in Skp2/
cells is not dependent on p27 accumulation. The amount We also measured the rate of cyclin E degradation by
treatment of MEFs with the protein synthesis inhibitorof phosphorylated cyclin E in MEFs was similar for the
four genotypes (Supplemental Figure S2A at http:// cycloheximide. In asynchronously cycling cells, cyclin
E appeared to be more stable in Skp2/ and Skp2/www.developmentalcell.com/cgi/content/full/6/5/
661/DC1), suggesting that the cyclin E that accumulates p27/ cells than in wild-type or p27/ cells (Figures
7B and 7C). This result was verified by pulse-chasein Skp2/ mice is the nonphosphorylated form. The
p27-related CKIs p21 and p57, both of which are also experiments (Supplemental Figure S3). Furthermore,
cyclin E was rapidly degraded after the release of wild-targets of Skp2-mediated ubiquitylation (Bornstein et
al., 2003; Kamura et al., 2003), were also examined for type and p27/ MEFs from S phase arrest induced by
aphidicolin treatment (Figures 7D and 7E); in contrast,their binding to cyclin E in wild-type, Skp2/, p27/,
and Skp2/ p27/ MEFs. Like p27, more p21 was asso- the degradation of cyclin E after release from aphidicolin
block was markedly delayed in Skp2/ and Skp2/ciated with cyclin E in Skp2/ MEFs than in wild-type
MEFs (Supplemental Figure S2B); the increase in the p27/ MEFs. In addition, our previous biochemical
Role of Skp2 in G2-M Progression
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cyclin E is a candidate substrate of SCFSkp2, and that
accumulation of cyclin E alone is not the cause of the
cellular abnormalities of Skp2/ mice.
Discussion
p27 Is a Major Physiological Target of SCFSkp2
Protein degradation by the ubiquitin-proteasome path-
way plays a fundamental role in determining the abun-
dance of important regulatory molecules. The E3 ubiqui-
tin ligases are thought to determine the substrate
specificity of this pathway, and many diverse E3 mole-
cules are therefore thought to exist, although it does
not appear to be unusual that several proteins serve as
substrates for a given ubiquitin ligase. Skp2, the sub-
strate-recognizing component of an SCF ubiquitin li-
gase, has thus been shown to recognize p27 (Carrano
et al., 1999; Sutterluty et al., 1999; Tsvetkov et al., 1999;
Nakayama et al., 2000), the p27-related CKIs p21 (Yu et
al., 1998; Bornstein et al., 2003) and p57 (Kamura et al.,
2003), cyclin A (Nakayama et al., 2000), cyclin D1 (Yu et
al., 1998), free cyclin E (Nakayama et al., 2000), E2F-1
(Marti et al., 1999), p130 (Tedesco et al., 2002; Bhatta-
charya et al., 2003), ORC1 (Mendez et al., 2002), Cdt1
(Li et al., 2003), Cdk9 (Kiernan et al., 2001), c-Myc (Kim
et al., 2003; von der Lehr et al., 2003), and B-Myb (Char-
rasse et al., 2000). Of these proteins, cyclin A, cyclin D1,
E2F-1, and Cdt1 do not accumulate in Skp2/ cells
(Nakayama et al., 2000) (our unpublished data), sug-
gesting either that they are not bona fide substrates of
Skp2 or that there is redundancy that allows for their
ubiquitylation in the absence of Skp2.
Most of the cellular abnormalities apparent in Skp2/
mice are not evident in Skp2/ p27/ double mutant
mice. This observation constitutes genetic evidence that
the cellular phenotype of nuclear enlargement with poly-
ploidy and overduplication of centrosomes in Skp2/
mice results from the deregulated expression of p27
during the cell cycle, and that p27 is likely the main target
of the SCFSkp2 ubiquitin ligase. However, the observation
Figure 6. Induction of Nuclear Enlargement by Inhibition of the Ki- that the phenotype of Skp2/ p27/ mice is not com-
nase Activity of Cdc2 pletely identical to that of p27/ mice suggests the
(A–D) Wild-type MEFs were incubated for 72 hr with dimethyl sulfox- existence of additional target proteins for Skp2-medi-
ide (vehicle control) (A) or with 80 M butyrolactone I (B), after ated ubiquitylation.
which they were subjected to immunostaining with antibodies to
pericentrin (green) or to -tubulin (red). Blue staining represents
Role of Skp2 in Prevention of p27 AccumulationHoechst 33258 labeling of nuclear DNA. Scale bar, 20 m. The DNA
content (C) and forward light scatter (FSC) (D) of the cells cultured in during S and G2 Phases
the absence (dotted lines) or presence (solid lines) of butyrolactone I The concentration of p27 is relatively high in quiescent
were also measured by flow cytometry. (G0) cells, decreases on entry of cells into the cell cycle,(E–J) FT210 cells (G and H), which express a temperature-sensitive
and is controlled predominantly by the rate of p27 degra-mutant of Cdc2, and the parental FM3A cells (E and F) were cultured
dation (Pagano et al., 1995; Shirane et al., 1999) as wellat 32C (permissive temperature) (E and G) or 39C (restrictive tem-
as by translational regulation (Hengst and Reed, 1996).perature) (F and H), after which they were subjected to immunostain-
ing with antibodies to pericentrin (green) and to staining of DNA with This degradation has been thought to require Skp2,
propidium iodide (red). The images were taken by laser-scanning which binds to p27 when the latter is phosphorylated
confocal microscopy. Scale bar, 10 m. FT210 cells cultured at the on Thr187 by the cyclin E–Cdk2 complex (Sheaff et al.,
permissive (dotted lines) or restrictive (solid lines) temperature were
1997; Vlach et al., 1997; Carrano et al., 1999; Montagnolialso subjected to flow cytometric analysis of DNA content (I) or
et al., 1999; Sutterluty et al., 1999; Tsvetkov et al., 1999).forward light scatter (J).
The primary function of SCFSkp2 might therefore be to
render quiescent cells competent to reenter the cell
cycle by mediating the degradation of p27. However,studies indicated that Skp2 specifically interacts with
cyclin E and thereby promotes its ubiquitylation and there are several inconsistencies with this notion. Skp2
and cyclin E are not expressed until the G1-S transitiondegradation both in vivo and in vitro (Nakayama et al.,
2000). Collectively, these findings suggest that free of the cell cycle, unequivocally later than the onset of
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Figure 7. Impaired Degradation of Cyclin E
in Skp2/ Mice Is Independent of p27
(A) Immunoblot analysis of cyclin E (left pan-
els) and -tubulin (control; right panels) in ly-
sates prepared from MEFs, thymus, testis,
and liver of wild-type, Skp2/, p27/, and
Skp2/ p27/ mice.
(B) Proliferating wild-type, Skp2/, p27/,
or Skp2/ p27/ MEFs were incubated in
the presence of cycloheximide (50 g/ml) for
the indicated times, after which cell lysates
were subjected to immunoblot analysis with
antibodies to cyclin E.
(C) The band intensities in (B) were quanti-
tated by image analysis and expressed as
a percentage of the corresponding value for
time zero.
(D) Wild-type, Skp2/, p27/, or Skp2/
p27/ MEFs were synchronized at S phase
by treatment with aphidicolin (1 g/ml) for
15 hr and then released into aphidicolin-free
medium for the indicated times, after which
cell lysates were prepared and subjected to
immunoblot analysis with antibodies to cy-
clin E.
(E) The band intensities in (D) were quanti-
tated and expressed as described in (C).
p27 degradation apparent at mid-G1 phase (Hara et al., In contrast, the degradation of p27 during S and G2
phases is impaired in Skp2/ mice, suggesting that the2001). Moreover, p27 is exported from the nucleus to
the cytoplasm at G0-G1 (Tomoda et al., 1999; Rodier et primary function of Skp2 is to prevent both the accumu-
lation of p27 during S and G2 phases and the consequental., 2001; Ishida et al., 2002; Connor et al., 2003), whereas
Skp2 is restricted to the nucleus (Miura et al., 1999). inhibition of mitotic cyclin-Cdc2 activity. Consistent with
this idea, experimental inhibition of the kinase activityThe discrepancies between the temporal and spatial
patterns of p27 expression and those of Skp2 expres- of Cdc2 in budding yeast, fission yeast, and Drosophila
forces cells that are normally mitotic to become endo-sion suggest the existence of a Skp2-independent path-
way for the degradation of p27. Indeed, the downregula- replicative (Edgar and Orr-Weaver, 2001). In the present
study, we show that this is also the case, at least intion of p27 at the G0-G1 transition occurs normally in
Skp2/ cells and is sensitive to proteasome inhibitors part, in mammals. Cell cycle synchronization of Skp2/
MEFs also revealed a delay at the G2-M boundary in com-(Hara et al., 2001). Biochemical analysis of crude ex-
tracts of Skp2/ cells revealed the presence in the cyto- parison with wild-type and Skp2/ p27/ cells (Supple-
mental Figure S4 at http://www.developmentalcell.com/plasmic fraction of an Skp2-independent E3 activity that
mediates the ubiquitylation of p27 (Hara et al., 2001). cgi/content/full/6/5/661/DC1). These data suggest that
inactivation of Cdc2 by p27 that accumulates as a resultThis ubiquitylation was not dependent on the phosphor-
ylation of p27 on Thr187, which is a prerequisite for Skp2- of the lack of Skp2 leads to G2-M block, although the
detailed mechanism of this phenomenon remains to bemediated ubiquitylation. These data indicate that p27
is degraded at the G0-G1 transition by a proteasome- determined. We thus propose that the major target of
p27 at G1 phase is Cdk2, and that at G2 phase it maydependent, but Skp2-independent, mechanism.
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be Cdc2; Skp2 seems to be important for the regulation A fission yeast mutant that lacks the F box protein
Pop1, which targets the CKI Rum1 for degradation, alsoof the latter.
exhibits endoreplication and consequent polyploidy
(Kominami and Toda, 1997). Rum1 accumulates to highEndoreplication of Hepatocytes Induced
levels in this mutant. Maintenance of ploidy in fissionby Deregulation of p27 Degradation
yeast is controlled by a complex of Cdc2 with the mitoticPolyploidy is apparent in certain tissues of Skp2/ mice
cyclin Cdc13. Inhibition of the kinase activity of Cdc2-including the liver. Maintenance of genome ploidy is
Cdc13 as a result of the increased expression of Rum1a fundamental aspect of cell division. Three possible
in the pop1 mutant thus likely leads to polyploidy bymechanisms might render cells polyploid. (1) Failure of
promoting the bypass of M phase before the next Smitosis. Cells enter mitosis normally but anaphase fails
phase. A mitotic cyclin-Cdk complex in budding yeastto occur, resulting in the subsequent entry of the cells
prevents endoreplication through multiple overlappinginto interphase with a doubled DNA content. (2) Endo-
mechanisms, including phosphorylation of the originreplication. Cells replicate their genomes in S phase,
recognition complex (ORC), downregulation of Cdc6 ac-bypass mitosis, and double their DNA content again in
tivity, and exclusion from the nucleus of the Mcm2-7the next S phase. (3) DNA rereplication. Cells arrest in
complex (Nguyen et al., 2001). Given the similarities inS phase and reinitiate DNA replication continuously. We
the phenotypes of the fission yeast pop1 mutant andadopted two criteria to determine which of these three
mouse Skp2/ cells, the accumulation of p27 in Skp2/mechanisms gives rise to the polyploidy of Skp2/ he-
cells may functionally correspond to that of Rum1 in thepatocytes. First, we examined whether cells entered
pop1 mutant. The prevention of endoreplication throughmitosis. Immunofluorescence analysis with antibodies
degradation of a CKI mediated by an SCF ubiquitin li-to phosphorylated histone H3, a marker of early mitosis,
gase thus appears to be a mechanism that has beenrevealed that the number of mitotic cells is reduced in
well conserved from yeast to mammals.the liver of Skp2/ mice, suggesting that failure of mito-
sis is not likely responsible for the polyploidy in these
animals. Second, we measured the DNA content of Free Cyclin E as a Potential Substrate of SCFSkp2
The marked accumulation of cyclin E in the absence ofSkp2/hepatocytes after mitogenic stimulation in order
to determine whether the increase in DNA content oc- the antagonizing action of p27 in Skp2/ p27/ mice
might have been expected either to compromise tissuecurred in a stepwise manner. The DNA content of
Skp2/ cells was shown to increase in multiples of organization in the developing embryo, and thereby to
result in early embryonic death, or to lead to a high2C, a characteristic of endoreplication, rather than in a
continuous manner, as would be consistent with DNA incidence of carcinogenesis. The apparent absence of
such outcomes suggests that the deregulated expres-rereplication (data not shown). Similar results were also
obtained after partial hepatectomy in Skp2/ mice (Mi- sion of cyclin E might not be a direct cause of carcino-
genesis, even though altered expression of cyclin E isnamishima et al., 2002). We thus conclude that the poly-
ploidy of Skp2/ hepatocytes is likely attributable to apparent in many human cancers. The cyclin E that
accumulates in Skp2/ mice, however, appears to beendoreplication, although the possibility of a mitotic de-
fect cannot be formally ruled out. the free form of the protein (Nakayama et al., 2000),
not that complexed with Cdk2, and therefore does notThe regulation of Cdk activity during endoreplication
in mammalian cells, with the exception of megakaryo- contribute to the kinase activity of Cdk2. The nature of
the interaction between the pool of free cyclin E andcytes and trophoblasts, is poorly understood (Edgar and
Orr-Weaver, 2001). Consistent with the association of the cyclin E-Cdk2 complex is unclear, but our present
data suggest that a simple increase in the abundanceSkp2 with Cul1 in the SCF ubiquitin ligase complex, the
phenotype of trophoblasts of Cul1/ embryos is similar of free cyclin E does not directly result in the activation
of Cdk2. Another possible interpretation of our data isto that of Skp2/ cells (Dealy et al., 1999; Wang et al.,
1999). Unlike most cells, trophoblasts undergo multiple that the increase in the pool of free cyclin E in Skp2/
cells results in an increase in the activity of the cyclinrounds of DNA synthesis without an intervening mitosis,
resulting in the formation of giant nuclei (Zybina and E-Cdk2 complex, but that this effect is antagonized by
the accumulated p27.Zybina, 1996). The lack of Cul1 or Skp2 appears to aug-
ment this process, and our present data indicate that Our data do not necessarily imply that SCFSkp2 is the
main mediator of cyclin E turnover. Rather, the mecha-the accumulation of p27 may play an important role in
its induction. The abundance of cyclin E remains high nisms for the degradation of cyclin E appear complex.
The Skp2-Cul1 complex and Cul3 interact with the free,and that of cyclin B is reduced in a differentiating tropho-
blast cell line, and p57, which is structurally and func- nonphosphorylated form of cyclin E (Dealy et al., 1999;
Singer et al., 1999; Wang et al., 1999; Nakayama et al.,tionally similar to p27, is upregulated during S phase in
these cells (Hattori et al., 2000). These characteristics 2000), thereby mediating its ubiquitylation-dependent
proteolysis. In parallel with these pathways, SCFFbw7 isresemble those of Skp2/ cells. However, ectopic ex-
pression of a form of p57 with a mutation that stabilizes thought to target phosphorylated cyclin E complexed
with Cdk2 (Clurman et al., 1996; Won and Reed, 1996;the protein blocks S phase entry in the trophoblast cell
line. The gradual increase in the abundance of p27 in Koepp et al., 2001; Moberg et al., 2001; Strohmaier et
al., 2001). However, mice that lack Fbw7, which die inSkp2/ cells may give rise to a window in which p27
inhibits mitosis but not entry into S phase, whereas utero during embryogenesis, show neither accumulation
of cyclin E nor an increase in Cdk2 activity (Tsunematsuforced expression of p57 at high levels may block S
phase entry immediately. et al., 2004), whereas Skp2/ mice manifest marked
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p27 (57, Transduction Laboratories), or -tubulin (TU-01, Zymed),accumulation of cyclin E in the nucleus. Thus, Fbw7
each at a concentration of 0.2 g/ml.appears to be dispensable for cyclin E degradation, at
In some experiments, subconfluent COS-7 cells grown in four 100least until mid-embryogenesis. In contrast, depletion of
mm dishes were transfected with 5 g of pcDNA3 or pcDNA-FLAG-
Fbw7 by RNA interference results in the accumulation p27 and with 2 g of pCD19 (Tedder and Isaacs, 1989) per dish with
of cyclin E in cultured cells (Koepp et al., 2001) (our the use of the FuGENE6 reagent (Roche Molecular Biochemicals).
Twenty-four hours after transfection, the CD19-expressing cellsunpublished observations), suggesting that Fbw7 might
were collected with antibodies to CD19 attached to magnetic beadsbe required for cyclin E turnover in adult tissues. These
(Dynal Biotech) and were used for immune-complex kinase assaysdata render unlikely, however, the possibility that the
and immunoprecipitation.loss of Skp2 might stabilize other proteins that impair
the Fbw7-dependent pathway of protein degradation Immune-Complex Kinase Assays
and are thereby responsible for the accumulation of Kinase activity associated with Cdk2, Cdc2, or cyclins A, B, or E
cyclin E. was measured with an immune-complex kinase assay as described
(Nakayama et al., 1996).Given that p27 accumulates to a high level in Skp2/
cells, it is possible that autophosphorylation of cyclin E
Mitogenic Stimulation of Mouse Hepatocytescomplexed with Cdk2 is inhibited by this CKI, resulting
by Oral Administration of Estriol
in stabilization of cyclin E. The accumulation of cyclin Male mice at 8 weeks of age were subjected to oral administration
E might thus be secondary to the increase in the abun- of 0.4 mg of estriol (Wako) per gram of body mass. They were
dance of p27. Our present data, however, have shown also subjected to daily intraperitoneal injection of BrdU (100 g/g)
(Sigma). Colchicine (1 g/g) (Wako) was injected intraperitoneally 6that cyclin E degradation is also impaired in Skp2/
hr before killing. Sections of the liver were stained with hematoxylin-p27/ mice, providing genetic evidence that the altered
eosin or were subjected to immunostaining with rabbit polyclonalexpression of cyclin E in Skp2/ cells is independent
antibodies to phosphorylated histone H3 (Upstate Biotechnology)
of p27 accumulation. We have previously shown that followed by Cy3-conjugated goat antibodies to rabbit immunoglob-
Skp2 interacts with free cyclin E and promotes its ubiqui- ulin G (Chemicon). For detection of BrdU, sections were incubated
tylation both in vitro and in vivo, and that cyclin E degra- with a rat monoclonal antibody to BrdU (Harlan Sera-Lab) at a dilu-
tion of 1:200 followed by biotinylated secondary antibodies; immunedation is impaired, resulting in loss of periodicity of
complexes were visualized with the use of a streptavidin-biotin-cyclin E expression, in Skp2/ cells (Nakayama et al.,
peroxidase detection kit (Vector) and diaminobenzidine (Wako).2000). These biochemical observations are therefore
consistent with the genetic evidence that Skp2 directly
Acknowledgments
targets cyclin E. It remains possible that the accumula-
tion of CKIs such as p21, p107, and p130 in Skp2/ We thank M. Fujita for helpful discussions, R. Tsunematsu, M. Mat-
sumoto, T. Hara, Y. Yamada, K. Shimoharada, S. Matsushita, N.mice contributes to the stabilization of cyclin E, although
Nishimura, R. Yasukochi, A. Ito, Y. Ono, and other laboratory mem-our observation that the kinase activity of Cdk2 is un-
bers for technical assistance, and M. Kimura and C. Sugita for helpchanged in Skp2/ cells suggests against this possi-
in preparation of the manuscript. This work was supported in partbility.
by a research grant from the Human Frontier Science Program.
Experimental Procedures Received: September 25, 2003
Revised: March 19, 2004
Mice Accepted: March 24, 2004
Both Skp2-deficient mice and p27-deficient mice were generated Published: May 10, 2004
in our laboratory (Nakayama et al., 1996, 2000). We have developed
polymerase chain reaction-based protocols (details available on re- References
quest) to identify wild-type and disrupted alleles of Skp2 and p27.
Bhattacharya, S., Garriga, J., Calbo, J., Yong, T., Haines, D.S., and
Histological and Immunofluorescence Analyses Grana, X. (2003). SKP2 associates with p130 and accelerates p130
Histological analysis and immunofluorescence analysis of centro- ubiquitylation and degradation in human cells. Oncogene 22, 2443–
somes and microtubules were performed as described (Nakayama 2451.
et al., 2000). Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano,
M., and Hershko, A. (2003). Role of the SCFSkp2 ubiquitin ligase in the
Preparation of MEFs degradation of p21Cip1 in S phase. J. Biol. Chem. 278, 25752–25757.
Primary MEFs were isolated from embryos on embryonic day 13.5 Carrano, A.C., Eytan, E., Hershko, A., and Pagano, M. (1999). SKP2
and cultured as previously described (Nakayama et al., 1996). In is required for ubiquitin-mediated degradation of the CDK inhibitor
asynchronous culture, there was no substantial difference in cell p27. Nat. Cell Biol. 1, 193–199.
cycle profiles among wild-type, Skp2/, p27/, and Skp2/ p27/
Charrasse, S., Carena, I., Brondani, V., Klempnauer, K.H., and Fer-MEFs (Supplemental Figure S4A at http://www.developmentalcell.
rari, S. (2000). Degradation of B-Myb by ubiquitin-mediated proteol-com/cgi/content/full/6/5/661/DC1).
ysis: involvement of the Cdc34-SCF(p45Skp2) pathway. Oncogene
19, 2986–2995.
Flow Cytometry
Clurman, B.E., Sheaff, R.J., Thress, K., Groudine, M., and Roberts,Flow cytometric analysis of hepatocytes and MEFs was performed
J.M. (1996). Turnover of cyclin E by the ubiquitin-proteasome path-as described previously (Nakayama et al., 1996, 2000).
way is regulated by cdk2 binding and cyclin phosphorylation. Genes
Dev. 10, 1979–1990.
Immunoblot Analysis
Connor, M.K., Kotchetkov, R., Cariou, S., Resch, A., Lupetti, R.,Transfection, immunoprecipitation, and immunoblot analysis were
Beniston, R.G., Melchior, F., Hengst, L., and Slingerland, J.M. (2003).performed as previously described (Hatakeyama et al., 1999; Kita-
CRM1/Ran-mediated nuclear export of p27(Kip1) involves a nucleargawa et al., 1999). Antibodies used in this study include those to
export signal and links p27 export and proteolysis. Mol. Biol. Cellcyclin A (H-432, Santa Cruz Biotechnology), cyclin B (GNS-1, Phar-
14, 201–213.Mingen), cyclin E (M-20, Santa Cruz Biotechnology), Cdk2 (M2,
Santa Cruz Biotechnology), Cdc2 (17, Santa Cruz Biotechnology), Correa-Bordes, J., and Nurse, P. (1995). p25rum1 orders S phase
Role of Skp2 in G2-M Progression
671
and mitosis by acting as an inhibitor of the p34Cdc2 mitotic kinase. ubiquitin ligase complex interacts with the human replication licens-
ing factor Cdt1 and regulates Cdt1 degradation. J. Biol. Chem.Cell 83, 1001–1009.
278, 30854–30858.Dealy, M., Nguyen, K.V.T., Lo, J., Gstaiger, M., Krek, W., Elson, D.,
Marti, A., Wirbelauer, C., Scheffner, M., and Krek, W. (1999). Interac-Arbeit, J., Kipreos, E.T., and Johnson, R.S. (1999). Loss of Cul1
tion between ubiquitin-protein ligase SCFSKP2 and E2F–1 underliesresults in early embryonic lethality and dysregulation of cyclin E.
the regulation of E2F–1 degradation. Nat. Cell Biol. 1, 14–19.Nat. Genet. 23, 245–248.
Mendez, J., Zou-Yang, X.H., Kim, S.Y., Hidaka, M., Tansey, W.P.,Edgar, B.A., and Orr-Weaver, T.L. (2001). Endoreplication cell cycles:
and Stillman, B. (2002). Human origin recognition complex largemore for less. Cell 105, 297–306.
subunit is degraded by ubiquitin-mediated proteolysis after initiation
Fero, M.L., Rivkin, M., Tasch, M., Porter, P., Carow, C.E., Firpo, E.,
of DNA replication. Mol. Cell 9, 481–491.
Polyak, K., Tsai, L.H., Broudy, V., Perlmutter, R.M., et al. (1996).
Minamishima, Y.A., Nakayama, K., and Nakayama, K.I. (2002). Re-A syndrome of multiorgan hyperplasia with features of gigantism,
covery of liver mass without proliferation of hepatocytes after partialtumorigenesis, and female sterility in p27Kip1-deficient mice. Cell
hepatectomy in Skp2-deficient mice. Cancer Res. 62, 995–999.85, 733–744.
Miura, M., Hatakeyama, S., Hattori, K., and Nakayama, K.I. (1999).Fujii, H., Hayama, T., and Kotani, M. (1985). Stimulating effect of
Structure and expression of the gene encoding mouse F-Box pro-natural estrogens on proliferation of hepatocytes in adult mice. Acta
tein, Fwd2. Genomics 62, 50–58.Anat. 121, 174–178.
Moberg, K.H., Bell, D.W., Wahrer, D.C., Haber, D.A., and Hariharan,Hara, T., Kamura, T., Nakayama, K., Oshikawa, K., Hatakeyama,
I.K. (2001). Archipelago regulates Cyclin E levels in Drosophila andS., and Nakayama, K.I. (2001). Degradation of p27Kip1 at the G0-G1
is mutated in human cancer cell lines. Nature 413, 311–316.transition mediated by a Skp2-independent ubiquitination pathway.
Montagnoli, A., Fiore, F., Eytan, E., Carrano, A.C., Draetta, G.F.,J. Biol. Chem. 276, 48937–48943.
Hershko, A., and Pagano, M. (1999). Ubiquitination of p27 is regu-Hatakeyama, S., Kitagawa, M., Nakayama, K., Shirane, M., Matsu-
lated by Cdk-dependent phosphorylation and trimeric complex for-moto, M., Hattori, K., Higashi, H., Nakano, H., Okumura, K., Onoe,
mation. Genes Dev. 13, 1181–1189.K., et al. (1999). Ubiquitin-dependent degradation of IB is medi-
Nagahama, H., Hatakeyama, S., Nakayama, K., Nagata, M., Tomita,ated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1. Proc.
K., and Nakayama, K.I. (2001). Spatial and temporal expression pat-Natl. Acad. Sci. USA 96, 3859–3863.
terns of the cyclin-dependent kinase (CDK) inhibitors p27Kip1 and
Hattori, N., Davies, T.C., Anson-Cartwright, L., and Cross, J.C.
p57Kip2 during mouse development. Anat. Embryol. 203, 77–87.
(2000). Periodic expression of the cyclin-dependent kinase inhibitor
Nakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shi-p57Kip2 in trophoblast giant cells defines a G2-like gap phase of the
shido, N., Horii, I., Loh, D.Y., and Nakayama, K.I. (1996). Mice lackingendocycle. Mol. Biol. Cell 11, 1037–1045.
p27Kip1 display increased body size, multiple organ hyperplasia, reti-
Hengst, L., and Reed, S.I. (1996). Translational control of p27Kip1 nal dysplasia, and pituitary tumors. Cell 85, 707–720.
accumulation during the cell cycle. Science 271, 1861–1864.
Nakayama, K., Nagahama, H., Minamishima, Y.A., Matsumoto, M.,
Ishida, N., Hara, T., Kamura, T., Yoshida, M., Nakayama, K., and Nakamichi, I., Kitagawa, K., Shirane, M., Tsunematsu, R., Tsukiyama,
Nakayama, K.I. (2002). Phosphorylation of p27Kip1 on serine 10 is T., Ishida, N., et al. (2000). Targeted disruption of Skp2 results in
required for its binding to CRM1 and nuclear export. J. Biol. Chem. accumulation of cyclin E and p27Kip1, polyploidy and centrosome
277, 14355–14358. overduplication. EMBO J. 19, 2069–2081.
Kamura, T., Hara, T., Kotoshiba, S., Yada, M., Ishida, N., Imaki, H., Nakayama, K.I., Hatakeyama, S., and Nakayama, K. (2001). Regula-
Hatakeyama, S., Nakayama, K., and Nakayama, K.I. (2003). Degrada- tion of the cell cycle at the G1-S transition by proteolysis of cyclin
tion of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proc. E and p27Kip1. Biochem. Biophys. Res. Commun. 282, 853–860.
Natl. Acad. Sci. USA 100, 10231–10236.
Nguyen, V.Q., Co, C., and Li, J.J. (2001). Cyclin-dependent kinases
Kiernan, R.E., Emiliani, S., Nakayama, K., Castro, A., Labbe, J.C., prevent DNA re-replication through multiple mechanisms. Nature
Lorca, T., Nakayama, K.I., and Benkirane, M. (2001). Interaction be- 411, 1068–1073.
tween cyclin T1 and SCFSKP2 targets CDK9 for ubiquitination and
Pagano, M., Tam, S.W., Theodoras, A.M., Beer-Romero, P., Del Sal,
degradation by the proteasome. Mol. Cell. Biol. 21, 7956–7970.
G., Chau, V., Yew, P.R., Draetta, G.F., and Rolfe, M. (1995). Role of
Kim, S.Y., Herbst, A., Tworkowski, K.A., Salghetti, S.E., and Tansey, the ubiquitin-proteasome pathway in regulating abundance of the
W.P. (2003). Skp2 regulates myc protein stability and activity. Mol. cyclin-dependent kinase inhibitor p27. Science 269, 682–685.
Cell 11, 1177–1188.
Rodier, G., Montagnoli, A., Marcotullio, D.L., Coulombe, P., Draetta,
Kitagawa, M., Okabe, T., Ogino, H., Matsumoto, H., Suzuki-Taka- D.G., Pagano, M., and Meloche, S. (2001). p27 cytoplasmic localiza-
hashi, I., Kokubo, T., Higashi, H., Saitoh, S., Taya, Y., Yasuda, H., tion is regulated by phosphorylation on Ser10 and is not a prerequi-
et al. (1993). Butyrolactone I, a selective inhibitor of cdk2 and Cdc2 site for its proteolysis. EMBO J. 20, 6672–6682.
kinase. Oncogene 8, 2425–2432. Sheaff, R.J., Groudine, M., Gordon, M., Roberts, J.M., and Clurman,
Kitagawa, M., Hatakeyama, S., Shirane, M., Matsumoto, M., Ishida, B.E. (1997). Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev.
N., Hattori, K., Nakamichi, I., Kikuchi, A., Nakayama, K.I., and Naka- 11, 1464–1478.
yama, K. (1999). An F-box protein, FWD1, mediates ubiquitin-depen- Shirane, M., Harumiya, Y., Ishida, N., Hirai, A., Miyamoto, C., Hata-
dent proteolysis of -catenin. EMBO J. 18, 2401–2410. keyama, S., Nakayama, K.I., and Kitagawa, M. (1999). Down-regula-
tion of p27Kip1 by two mechanisms, ubiquitin-mediated degradationKiyokawa, H., Kineman, R.D., Manova-Todorova, K.O., Soares, V.C.,
and proteolytic processing. J. Biol. Chem. 274, 13886–13893.Hoffman, E.S., Ono, M., Khanam, D., Hayday, A.C., Frohman, L.A.,
and Koff, A. (1996). Enhanced growth of mice lacking the cyclin- Singer, J.D., Gurian-West, M., Clurman, B., and Roberts, J.M. (1999).
dependent kinase inhibitor function of p27Kip1. Cell 85, 721–732. Cullin-3 targets cyclin E for ubiquitination and controls S phase in
mammalian cells. Genes Dev. 13, 2375–2387.Koepp, D.M., Schaefer, L.K., Ye, X., Keyomarsi, K., Chu, C., Harper,
J.W., and Elledge, S.J. (2001). Phosphorylation-dependent ubiquiti- Stern, B., and Nurse, P. (1996). A quantitative model for the Cdc2
nation of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294, control of S phase and mitosis in fission yeast. Trends Genet. 12,
173–177. 345–350.
Kominami, K., and Toda, T. (1997). Fission yeast WD-repeat protein Strohmaier, H., Spruck, C.H., Kaiser, P., Won, K.A., Sangfelt, O., and
pop1 regulates genome ploidy through ubiquitin-proteasome-medi- Reed, S.I. (2001). Human F-box protein hCdc4 targets cyclin E for
ated degradation of the CDK inhibitor Rum1 and the S-phase initiator proteolysis and is mutated in a breast cancer cell line. Nature
Cdc18. Genes Dev. 11, 1548–1560. 413, 316–322.
Sutterluty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M.,Li, X., Zhao, Q., Liao, R., Sun, P., and Wu, X. (2003). The SCFSkp2
Developmental Cell
672
Muller, U., and Krek, W. (1999). p45SKP2 promotes p27Kip1 degradation
and induces S phase in quiescent cells. Nat. Cell Biol. 1, 207–214.
Tedder, T.F., and Isaacs, C.M. (1989). Isolation of cDNAs encoding
the CD19 antigen of human and mouse B lymphocytes. J. Immunol.
143, 712–717.
Tedesco, D., Lukas, J., and Reed, S.I. (2002). The pRb-related pro-
tein p130 is regulated by phosphorylation-dependent proteolysis
via the protein-ubiquitin ligase SCFSkp2. Genes Dev. 16, 2946–2957.
Th’ng, J.P., Wright, P.S., Hamaguchi, J., Lee, M.G., Norbury, C.J.,
Nurse, P., and Bradbury, E.M. (1990). The FT210 cell line is a mouse
G2 phase mutant with a temperature-sensitive CDC2 gene product.
Cell 63, 313–324.
Tomoda, K., Kubota, Y., and Kato, J. (1999). Degradation of the
cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Na-
ture 398, 160–165.
Tsunematsu, R., Nakayama, K., Oike, Y., Nishiyama, M., Ishida, N.,
Hatakeyama, S., Bessho, Y., Kageyama, R., Suda, T., and Nakayama,
K.I. (2004). Mouse Fbw7/Sel-10/Cdc4 is required for notch degrada-
tion during vascular development. J. Biol. Chem. 279, 9417–9423.
Tsvetkov, L.M., Yeh, K.H., Lee, S.J., Sun, H., and Zhang, H. (1999).
p27Kip1 ubiquitination and degradation is regulated by the SCFSkp2
complex through phosphorylated Thr187 in p27. Curr. Biol. 9,
661–664.
Vlach, J., Hennecke, S., and Amati, B. (1997). Phosphorylation-
dependent degradation of the cyclin-dependent kinase inhibitor
p27. EMBO J. 16, 5334–5344.
von der Lehr, N., Johansson, S., Wu, S., Bahram, F., Castell, A.,
Cetinkaya, C., Hydbring, P., Weidung, I., Nakayama, K., Nakayama,
K.I., et al. (2003). The F-box protein Skp2 participates in c-Myc
proteasomal degradation and acts as a cofactor for c-Myc-regulated
transcription. Mol. Cell 11, 1189–1200.
Wang, Y., Penfold, S., Tang, X., Hattori, N., Riley, P., Harper, J.W.,
Cross, J.C., and Tyers, M. (1999). Deletion of the Cul1 gene in mice
causes arrest in early embryogenesis and accumulation of cyclin E.
Curr. Biol. 9, 1191–1194.
Won, K.A., and Reed, S.I. (1996). Activation of cyclin E/CDK2 is
coupled to site-specific autophosphorylation and ubiquitin-depen-
dent degradation of cyclin E. EMBO J. 15, 4182–4193.
Yu, Z.K., Gervais, J.L., and Zhang, H. (1998). Human CUL-1 associ-
ates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1)
and cyclin D proteins. Proc. Natl. Acad. Sci. USA 95, 11324–11329.
Zybina, E.V., and Zybina, T.G. (1996). Polytene chromosomes in
mammalian cells. Int. Rev. Cytol. 165, 53–119.
